Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | GLI1 | P08151 | 1/20 | 0.56 |
| ▸ | GLI2 | P10070 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | ERCC1 | P07992 | 2/20 | 0.55 |
| ▸ | ERCC4 | Q92889 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30281537 | 1.00 | MAPT (0.65) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL28976208 | 1.00 | MAPT (0.65) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL28976184 | 0.88 | MAPT (0.61) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL9965254 | 0.88 | ERCC1 (0.71) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL4949922 | 0.86 | MAPT (0.67) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL5053837 | 0.86 | MAPT (0.67) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL28976207 | 0.86 | MAPT (0.58) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL31475411 | 0.85 | MAPT (0.65) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL1123655 | 0.85 | MAPT (0.65) | MAPTHSD17B10HIF1AKDM4EALDH1A1 | |
| SCHEMBL27269169 | 0.85 | MAPT (0.65) | MAPTHSD17B10HIF1AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0106335-B1 | PHARMACEUTICAL COMPOSITION AND A METHOD FOR ENHANCING THE ABSORPTION OF A PHARMACEUTICALLY ACTIVE COMPOUND | Tanabe Seiyaku Co., Ltd. (JP) | 1991-10-23 | — | — | EP | claimed |
| EP-0106335-A2 | Pharmaceutical composition and a method for enhancing the absorption of a pharmaceutically active compound | Tanabe Seiyaku Co., Ltd. (JP) | 1984-04-25 | — | — | EP | claimed |
| CN-119950467-A | Application of N-beta-alanyl dopamine or salt thereof in preparation of product for preventing and treating hepatic fibrosis | 首都医科大学 | 2025-05-09 | — | — | CN | disclosed |
| US-11904014-B2 | Immunostimulatory compositions | Assistance Publique—Hopitaux de Paris (FR) | 2024-02-20 | — | — | US | disclosed |
| EP-3380120-A1 | IMMUNOSTIMULATORY COMPOSITIONS | Assistance Publique - Hôpitaux de Paris (FR) | 2018-10-03 | — | — | EP | disclosed |
| WO-2017089529-A1 | IMMUNOSTIMULATORY COMPOSITIONS | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) | 2017-06-01 | — | — | WO | disclosed |
| EP-0607394-A1 | DIPHOSPHATES OF CATECHOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ZAMBON GROUP S.p.A. (IT) | 1994-07-27 | — | — | EP | disclosed |
| WO-1994003461-A1 | DIPHOSPHATES OF CATECHOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ZAMBON GROUP S.P.A. (IT) | 1994-02-17 | — | — | WO | disclosed |
| EP-0106335-B1 | PHARMACEUTICAL COMPOSITION AND A METHOD FOR ENHANCING THE ABSORPTION OF A PHARMACEUTICALLY ACTIVE COMPOUND | Tanabe Seiyaku Co., Ltd. (JP) | 1991-10-23 | — | — | EP | disclosed |
| EP-0106335-A2 | Pharmaceutical composition and a method for enhancing the absorption of a pharmaceutically active compound | Tanabe Seiyaku Co., Ltd. (JP) | 1984-04-25 | — | — | EP | disclosed |
| EP-0007441-B1 | N - (N-ACETYL-L-METHIONYL) - 3,4 -DIETHOXY-CARBONYLOXY-PHENETHYLAMINE, PROCESS FOR PREPARING SAME AND A PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND. | Tanabe Seiyaku Co., Ltd. (JP) | 1981-11-25 | — | — | EP | disclosed |
| US-4228183-A | HYPOTENSIVE AGENTS | TANABE SEIYAKU CO., LTD. (JP) | 1980-10-14 | — | — | US | disclosed |
| EP-0007441-A1 | N - (N-Acetyl-L-methionyl) - 3,4 -diethoxy-carbonyloxy-phenethylamine, process for preparing same and a pharmaceutical composition containing said compound. | Tanabe Seiyaku Co., Ltd. (JP) | 1980-02-06 | — | — | EP | disclosed |
| US-4033997-A | Preparation of dopamine derivatives | ABBOTT LABORATORIES (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11904014-B2 | Immunostimulatory compositions | CD47, CD74, LY96 | MAPT 1875/4885HSD17B10 3511/4885HIF1A 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.